Digital Heath Integration With Neuromodulation Therapies on Sensory and Motor Function in Patients With Diabetic Neuropathy

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This study will be carried out on 60 patients both gender male and female with diabetic neuropathy with age55-65 years. The patients will be selected from Elmahmoudia hospital .patients will be randomly assigned to two groups.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 55
Maximum Age: 65
Healthy Volunteers: f
View:

• 1\. Diagnosis of diabetes based on World Health Organization (WHO) with ages from 55to 65years 2. BMI\> 25kg/m2 3. Clinically diagnosed with diabetic neuropathy. 4. All patients are taking oral hypoglycemic drugs with controlled diabetes mellitus.

• 5\. Willingness to comply with the study procedures and interventions. 6. Ability to provide informed consent. 7. presenting with Distal symmetric polyneuropathy (DSPN) based on a score of ≥7 on the validated Michigan Neuropathy Screening Instrument (MNSI) questionnaire.

• 8\. exhibiting moderately controlled blood pressure

Locations
Other Locations
Egypt
Faculty of Physical Therapy
RECRUITING
Dokki
Contact Information
Primary
alaa marzouk, master
alaamarzouk136@gmail.com
01001346787
Backup
marwa mahmoud, phd
marwadd999@gmail.com
01156033818
Time Frame
Start Date: 2024-11-10
Estimated Completion Date: 2025-12-30
Participants
Target number of participants: 60
Treatments
Experimental: experimental group
This group will include 30 type II diabetic patients with peripheral neuropathy Patients will receive TENS and NMES for 30 minutes 3 days per week,for 10 weeks with medical treatment
Placebo_comparator: control group
This group will include 30 type II diabetic patients with peripheral neuropathy Patients will receive placebo TENS and NMES for 30-min sessions, 3 days per week, for 10 weeks with medical treatment
Related Therapeutic Areas
Sponsors
Leads: Cairo University

This content was sourced from clinicaltrials.gov